Merck acquires remaining stake in Ormet Circuits - MarketLine Financial Deals

Merck acquires remaining stake in Ormet Circuits

Merck acquires remaining stake in Ormet Circuits - MarketLine Financial Deals
Merck acquires remaining stake in Ormet Circuits
Published Dec 14, 2015
3 pages — Published Dec 14, 2015
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Merck KGaA, a Germany-based pharmaceutical, chemicals and life science company, has acquired the remaining stake in Ormet Circuits, Inc.

  
Source:
Document ID
MA162921_151215
Country
Country
Ticker
MRCG=DE
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Merck acquires remaining stake in Ormet Circuits" Dec 14, 2015. Alacra Store. Dec 04, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Merck-acquires-remaining-stake-in-Ormet-Circuits-2052-116354>
  
APA:
MarketLine Financial Deals. (2015). Merck acquires remaining stake in Ormet Circuits Dec 14, 2015. New York, NY: Alacra Store. Retrieved Dec 04, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Merck-acquires-remaining-stake-in-Ormet-Circuits-2052-116354>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.